# Program Summary — {{DISEASE}}

> Stage-10 synthesis. One page the user can hand to a partner or investor. Every number must
> reconcile with the source artifact; every forward-looking claim is labeled as such.

## The program at a glance
- **Indication / scope:** {{DISEASE}} — {{POPULATION_SCOPE}}
- **Unmet need (patient-priority framed):** {{UNMET_NEED}}
- **Lead target(s) & modality:** {{LEAD_TARGETS}} — {{MODALITY}}
- **Validation status:** {{DESIGN_STATUS}} (e.g. leads at ipTM {{IPTM}}, caveats {{CAVEATS}})
- **Regulatory path:** {{REG_PATH}} (designations pursued: {{DESIGNATIONS}})
- **Market:** TAM {{TAM}} / SAM {{SAM}} / SOM {{SOM}}
- **The Ask:** {{ASK}} to reach {{VALUE_INFLECTION}}

## How we got here (stage trace)
| Stage | Outcome | Key artifact | Decision made by |
|------:|---------|--------------|------------------|
{{STAGE_TRACE_ROWS}}

## Decisions log
{{DECISIONS}}  ← from dossier.decisions (who decided what, and why)

## Open questions & risks requiring validation
{{OPEN_QUESTIONS}}  ← from dossier.open_questions

## Deliverable manifest
{{MANIFEST}}  ← from build_manifest(dossier): filename → stage → artifact link

---
*Generated by the drug-program-orchestration pipeline. Forward-looking scientific, regulatory,
and commercial statements are development hypotheses, not established results or advice.*